Abstract
Rationale
We showed that the metabolite peaks of 15N3-citrulline (15N3-CIT) and 15N3-arginine (15N3-ARG) could be detected when 15N4-ARG was metabolized by nitric oxide synthase (NOS) in endothelial cells. The usefulness of these metabolites as potential surrogate indices of nitric oxide (NO) generation is evaluated.
Methods
A hydrophilic-interaction liquid chromatography electrospray tandem mass spectrometric assay (LC-MS/MS) was utilized for the simultaneous analysis of 15N4-ARG, ARG, CIT, 15N3-CIT and 15N3-ARG. 15N3-CIT and 15N3-ARG from impurities of 15N4-ARG were determined and corrected for the calculation of their concentration. 15N4-ARG-derived NO, i.e., 15NO formation was determined by analyzing 15N-nitrite accumulation by another LC-MS/MS assay.
Results
After EA.hy926 human endothelial cells were challenged with 15N4-ARG for 2 hours, the peak intensities of 15N3-CIT and 15N3-ARG significantly increased with 15N4-ARG concentration and positively correlated with 15N-nitrite production. The estimated Km values were independent of the metabolite (i.e., 15N3-CIT, 15N3-CIT+15N3-ARG or 15N-nitrite) used for calculation. However, after correction for its presence as a chemical contaminant of 15N4-ARG, 15N3-ARG was only a marginal contributor for the estimation of NOS activity.
Conclusions
These data suggest that the formation of 15N3-CIT can be used as an indicator of NOS activity when 15N4-ARG is used as a substrate. This approach may be superior to the radioactive 14C-CIT method which can be contaminated by 14C-urea, and to the 14N-nitrite method which lacks sensitivity.
Keywords: L-arginine, L-citrulline, liquid chromatography tandem mass spectrometry, nitric oxide, nitric oxide synthase
1 Introduction
As an endogenous signaling molecule, nitric oxide (NO) is involved in a variety of physiological processes including blood pressure regulation, platelet aggregation/adhesion, neurotransmission as well as cellular defense.[1] Physiologically, NO is produced by the enzyme nitric oxide synthase (NOS) which converts L-arginine (ARG) into L-citrulline (CIT) and NO. NOS exists in a variety of isoforms including NOS1, NOS2 and NOS3 which are encoded by different genes.[2] While NOS1 is constitutively expressed in neuronal and certain epithelial cells, NOS2 is inducible with lipopolysaccharide and cytokines in a multitude of different cells. The last isoform, NOS3 (endothelial NOS, eNOS) has been found to be constitutively expressed in endothelial cells. The activities of NOS1 and NOS3 are known to be regulated by Ca2+ and calmodulin. In endothelial cells, NO keeps blood vessels dilated, prevents the adhesion of platelets and white cells, and inhibits vascular smooth muscle proliferation.[2] The loss of adequate production of NO in the endothelium is a major cause of endothelial dysfunction, which is a hallmark of a variety of cardiovascular diseases such as hypertension, atherosclerosis and diabetes.
Due to the pivotal role of NO in physiology, numerous analytical methods have been developed and used to quantify NO production via the NOS-mediated enzymatic conversion of ARG to NO.[3] Direct measurement of NO in biological fluid is extremely difficult because NO is a short-lived molecule with an estimated in vivo half-life in human blood of 3–5 seconds.[4] Therefore, oxidation end-products of NO, viz., inorganic nitrite and nitrate ions, are measured in blood and urine, and their accumulation has been used as an index of NO production. Various analytical approaches including colorimetric assay based on Griess reaction,[5] fluorometric assay[6] as well as gas chromatography-mass spectrometry[7] have been applied to measure nitrite and nitrate. However, the extent to which these ion fluxes represent quantitative NO production under diverse experimental conditions is unknown.[8] In addition, sources of nitrite and nitrate other than from ARG, e.g., dietary intake, would need to be accounted for.[9]
In addition to NO, CIT is also produced from ARG by NOS. This amino acid, however, is also formed via other pathways, such as the urea cycle and the dimethylarginine dimethylaminohydrolase-mediated metabolism of asymmetric dimethylarginine (ADMA). Thus, a simple quantitation of total CIT production does not provide an accurate estimation of NO production. In order to discriminate the NOS-derived CIT from other sources, radiolabeled ARG, usually using 3H or 14C, has been utilized to enable measurement of radioactive CIT.[10] In this assay, unreacted radiolabeled ARG is removed by retention on a cation exchange column which allows radiolabeled CIT to pass through the column, and NOS activity is determined simply by counting radioactivity in the effluent. However, it was pointed out that, without further chromatographic separation, arginase catalyzed conversion of 14C-ARG to 14C-urea would be included erroneously as part of the radioactive signal of 14C -CIT, as shown in rat liver mitochondria.[11]
We have reported a liquid chromatography tandem mass spectrometric (LC-MS/MS) assay for the simultaneous bioanalysis of ARG, 15N4-ARG, CIT, and methylated arginines.[12] Because discrete cellular compartments for ARG have been proposed,[13, 14] the use of isotope-labeled ARG, e.g., 15N4-ARG, as an exogenous substrate is advantageous since it allows insights into the relative dispositional fates of exogenous vs. endogenous ARG.
When applying this assay to cellular studies, we observed two chromatographic peaks in cell lysate samples after cells were exposed to 15N4-ARG.[12] These peaks were tentatively identified as those of 15N3-CIT and 15N3-ARG. Since 15N3-CIT can be formed with 15NO from the metabolism of 15N4-ARG by NOS, and it can then be further metabolized to 15N3-ARG via the urea cycle, monitoring of these peaks may theoretically allow for an estimation of NOS activity. The objective of the present study, therefore, is to evaluate the use of peak intensity of 15N3-CIT as surrogate index of NO production when an exogenous ARG source (15N4-ARG) is used. This approach was then compared to the extent of 15N-nitrite production in cultured human endothelial cells.
2 Materials and Methods
2.1 Chemicals and reagents
ARG [as L-arginine HCl], CIT [as L-citrulline], 4-(2-Hydroxyethyl)-1 piperazineethanesulfonic acid (HEPES), CaCl2·4H2O, bovine brain calmodulin, (6R)-5,6,7,8-tetrahydro-l-biopterin (BH4), NADPH, ethylene diamine tetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), and L-NG-Nitroarginine methyl ester (L-NAME) were purchased from Sigma (St. Louis, MO). 15N4-ARG [as its HCl, (U-15N4, 98%)], the internal standard for ARG, 13C6-ARG [as ARG:HCl (U-13C6, 98%)], the internal standard for CIT, D4-CIT [as L-citrulline (4,4,5,5-D4, 96.5 %)], and 15N-nitrite [as NaNO2 (15N, 98%+)] were obtained from Cambridge Isotope Laboratories, Inc. These compounds were used without further purification. Cell culture reagents were purchased from Invitrogen.
2.2 In vitro cell study
EA.hy926 human vascular endothelial cells, which is an immortalized cell line derived from human umbilical vein endothelial cells,[15] were obtained as a gift from the University of North Carolina. Cells were grown in a low glucose-low ARG modified Dulbecco’s modified Eagle’s medium (DMEM) containing 0.9 g·L−1 of glucose and 21 mg·L−1 of ARG[16] supplemented with 10 % fetal bovine serum, and 100 U·mL−1 penicillin and 100 μg·mL−1 streptomycin at 37 °C in a 5 % CO2 incubator for 7 days.
For intact cell experiments, cells were washed twice with phosphate-buffered saline and equilibrated in Locke’s solution (LS; 154 mM NaCl, 5.6 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 10 mM HEPES, 3.6 mM NaHCO3 and 5.6 mM glucose) for 1 hour before the experiment. Different concentrations of 15N4-ARG (0, 20, 50, 100, 200, 500 μM, equivalent to 0, 3.6, 8.9, 17.8, 35.6, 89.1 mg·L−1) were added to the cells. After 2 hours, the cell incubation medium was collected and cells were lysed and collected for analysis. For cell lysates experiments, cells were lysed with lysis buffer before the experiment. Different concentrations of 15N4-ARG (0, 5, 10, 20, 50, 100 μM, equivalent to 0, 0.9, 1.8, 3.6, 8.9, 17.8 mg·L−1) were added to the cell lysates. L-NAME (100 μM) was added to the reaction mixture to examine NOS inhibition. After 30 min, cell lysate samples were collected for analysis. Protein concentrations in the cell lysates were determined by Lowry assay.[17]
2.3 Rat liver mitochondria study
Mitochondria were isolated from an adult male Sprague Dawley rat liver according to Raha et al.[18] The isolated liver was finely minced and gently homogenized in homogenization buffer (50 mM HEPES pH 7.4, 70 mM sucrose, 220 mM mannitol, and 1 mM EGTA). Following homogenization the mixture was centrifuged at 3000 × g for 10 min. The supernatant was then centrifuged at 15,000 × g for 10 min. The pellet was gently solubilized in homogenization buffer and centrifugation steps were repeated. The pellet was resolubilized and recentrifuged at 15,000 × g for a final time and the final mitochondrial pellet was resuspended in buffer (0.34 M sucrose, 100 mM KCl, 10 mM Tris-Cl, 1 mM EDTA). The protein concentration was determined and adjusted to 5 mg·mL−1. The cytochrome c oxidase activity of the prepared mitochondria was measured by a colorimetric assay using a Cytochrome c Oxidase Assay Kit (Sigma, MO). The decrease in the absorbance at 550 nm was monitored by a spectrophotometer.
To assess metabolite production from exogenous ARG (15N4-ARG) in the mitochondria, reactions were run according to Venkatakrishnan et al.[11] An aliquot of 150 μg of isolated mitochondria was added to the reaction mixtures which consisted of 50 mM HEPES (pH 7.6), 400 μM NADPH, 400 μM CaCl2, 5 μM tetrahydrobiopterin, 50 μM 15N4-ARG, and 1.5-fold molar excess of calmodulin in a total volume of 0.25 mL. After incubation at 23 °C for 10 min, samples were collected for analysis.
2.4 LC-MS/MS assay for 15N3-CIT and 15N3-ARG
15N3-CIT and 15N3-ARG were analyzed by hydrophilic-interaction liquid chromatography electrospray tandem mass spectrometry along with ARG, 15N4-ARG, CIT, ADMA, and SDMA.[12] Briefly, an aliquot of 20 μL of the cell lysates or cell medium was mixed with 3 internal standards (20 μL of 13C6-ARG 1μM, 20 μL of D4-CIT 1 μM, and 20 μL of D7-ADMA 250 nM) and 120 μL of mobile phase B (acetonitrile containing 0.5% acetic acid and 0.025% trifluoroacetic acid) was added for protein precipitation. After centrifugation at 13,000 × g for 20 min, the supernatant was collected for analysis.
The liquid chromatography consists of Shimadzu LC-20AD delivery pump, SIL-20AC autosampler and CBM-20A system controller (Shimadzu Scientific Instruments; Columbia, MD). Analytes were separated by liquid chromatography on a 150×2.1 mm Alltima HP HILIC 3 μ column with an isocratic elution with 15 % mobile phase A (water containing 0.5 % acetic acid and 0.025 % trifluoroacetic acid) and 85 % mobile phase B (acetonitrile containing 0.5 % acetic acid and 0.025 % trifluoroacetic acid) at a flow rate of 0.25 mL·min−1 for 6 min.
[M+H]+ ions were analyzed in the multiple reaction monitoring mode of the ABI/Sciex API3000 triple quadrupole mass spectrometer (Applied Biosystems, Foster City, CA) equipped with an electrospray ion (ESI) source. To identify isotopomeric CIT and ARG metabolites of 15N4-ARG, MRM transitions of 179.2→71.1, 178.2→71.0, and 177.2→71.0 were added in the MS setting and monitored. The predicted MRM transitions of 15N3-CIT and 15N3-ARG are m/z 179.2→71.1 and 178.2→71.0, respectively. Due to the unavailability of authentic standards, 15N3-CIT and 15N3-ARG concentrations were estimated by assuming identical behaviors of isotopomeric compounds, using established calibration curves for unlabeled CIT and 15N4-ARG, respectively. D4-CIT and 13C6-ARG were used as internal standards, respectively. The MRM transitions of D4-CIT and 13C6-ARG are m/z 180.2 → 74.1 and 181.2 → 74.2, respectively.
2.5 LC-MS/MS assay for 15N-nitrite
15N-nitrite was determined by an LC-MS/MS assay.[19] An aliquot of cell lysates and cell medium sample 100 μL was first incubated with 10 μL of 0.5 mM 2,3-diaminonaphthalene (DAN, in 0.5 M HCl) for 10 min at room temperature to convert 15N-nitrite in the sample to 15N-2,3-naphthotriazole (15N-NAT) using the procedure reported by Misko et al.[6] After addition of acetonitrile for protein precipitation, samples were centrifuged at 13,000 × g for 5 min. An aliquot of 20 μL of the supernatant was then mixed with 5 μL of the internal standard, 1H-naphth[2,3-d]imidazole (5 ng·mL−1), and diluted with 170 μL of water and injected to LC-MS/MS. The liquid chromatography consisted of a Shimadzu LC-20AD delivery pump, SIL-20AC autosampler, and CBM-20A system controller (Shimadzu Scientific Instruments; Columbia, MD). Chromatographic separation was accomplished on Agilent XDB-C18, 2×50mm, 5 μ column by a gradient elution of 5% mobile phase B (0.1 % v/v formic acid in acetonitrile) in mobile phase A (0.1 % v/v formic acid in water), rising linearly to 95 % mobile phase B in 4 min. The flow rate was 0.3 mL/min. [M+H]+ ions were analyzed in the multiple reaction monitoring (MRM) mode of the ABI/Sciex API3000 triple quadrupole mass spectrometer (Applied Biosystems, Foster City, CA) equipped with an electrospray ion (ESI) source. The MRM transitions were m/z 170.1→115.0 for 14N-NAT, m/z 171.1→115.0 for 15N-NAT, and m/z 169.2→115.0 for the IS.
2.6 Kinetic calculations
NOS activity was assessed based on the production of various products, by fitting the observed data to the Michaelis-Menten equation.
where V is the reaction rate, Vmax is the maximum rate, S is the concentration of the substrate, i.e., 15N4-ARG, and Km is the substrate concentration at which the activity is half-maximal. The kinetic parameters, Vmax and Km were estimated by nonlinear regression of substrate dependence.
V was estimated by the accumulated amounts of either 15N-nitrite, 15N3-CIT, or 15N3-CIT + 15N3-ARG over the incubation time of 120 min, and corrected for protein content. Individual data were fitted to the Michaelis-Menten equation using WinNonlin 5.0 (Pharsight Corporation, Mountain View, CA).
2.7 Statistical analysis
Statistical analyses were performed using one-way ANOVA. Comparisons among different groups were followed using Tukey post hoc analysis. Differences with p<0.05 were denoted as statistically significant.
3 Results
3.1 Observation of new chromatographic peaks from cell samples after exposure to 15N4-ARG
After EA.hy 926 human endothelial cells were exposed to 15N4-ARG for 2 hours, cell lysate samples were analyzed to examine peaks representing a series of isotopomeric CIT and ARG compounds in the ion chromatogram. Based on the theoretical molecular masses and fragmentation patterns of possible metabolites, selected MRM transitions of 179.2→71.1, 178.2→71.0, and 177.2→71.0 were performed. Under each MRM transition, peaks with the retention time of CIT, 2.83 min, and that of ARG, 3.33 min were examined.
Fig. 1 shows the observed ion chromatograms with MRM transition of m/z 179.2→71.1(peak A), 178.2→71.0 (peak B), and 177.2→71.0 (peak C) with retention times of 2.83 min (that of CIT) and 3.33 min (that of ARG). The intensity of peak A and peak B increased in a saturable manner when EA.hy926 human endothelial cells were exposed to increasing extracellular 15N4-ARG concentrations (Supplementary Fig. S1A and B). However, the intensity of peak C was only marginally dependent on extracellular 15N4-ARG concentrations in appearance only, and statistical significance could not be demonstrated (p>0.05, Supplementary Fig. S1C).
Figure 1.
Representative ion chromatograms under MRM transitions of 179.2→71.1 (peak A), 178.2→71.0 (peak B), and 177.2→71.0 (peak C) in a human endothelial cell lysate sample obtained after cells were incubated with 100 μM of 15N4-ARG for 2 hours.
3.2 Tentative assignments of observed peaks
Table 1 shows the theoretical MRM transition and chromatographic properties of various CIT and ARG isomers. It is apparent that the observed characteristics of peak A were consistent with that of 15N3-CIT, and those of peak B with 15N3-ARG. Both of these compounds are generated as a result of metabolism of 15N4-ARG to CIT, and the back conversion of CIT to ARG (Fig. 2). Thus, peaks A and B were then tentatively assigned as those for 15N3-CIT and 15N3-ARG, respectively. The chromatographic characteristics of peak C are consistent with those of 15N2-ARG (Table 1). However, formal identity of these chromatographic peaks can only be made when the relevant authentic standard becomes available or when high resolution mass spectrometry technique is applied.[20]
Table 1.
LC-MS/MS properties of stable isotope-labeled isomers of CIT and ARG originating from the metabolism of 15N4-ARG.
Figure 2.
Schematic representation of 15N3-CIT and 15N3-ARG formation from 15N4-ARG. When 15N4-ARG is used as a substrate for NOS, 15N3-CIT is produced via NOS and subsequent urea cycle enzymes, argininosuccinate synthase (ASS) and argininosuccinate lyase (ASL), form 15N3-ARG. Further metabolism of 15N3-ARG by NOS produces unlabeled NO and 15N3-CIT.
3.3 Other sources of 15N3-CIT and 15N3-ARG in samples
To determine possible sources of these compounds from chemical contamination and blank cells, an experiment was carried out to examine their presence using a broad range of 15N4-ARG standard solutions (0, 1, 4, 10, and 20 μM, n=2 each) in blank cell lysates without incubation. The concentrations of 15N4-ARG standard solutions were chosen to cover the achievable intracellular 15N4-ARG concentration range after cells were challenged with 0 – 500 μM of 15N4-ARG.
When these samples were analyzed directly without incubation, there was no peak of 15N3-CIT found in the ion chromatogram, suggesting that this compound was generated by metabolism, rather than as an impurity. On the other hand, significant 15N3-ARG peaks were observed. The peak intensity of 15N3-ARG increased proportionally with the added 15N4-ARG concentration, with a mean value of 2.4 ± 0.3 % of 15N4-ARG (n=8), over the concentration range studied. This percentage was interpreted as arising from the presence of 15N3-ARG as an impurity in the 15N4-ARG commercial sample. In subsequent data analysis, therefore, all observed 15N3-ARG peak intensities were corrected for the presence of this compound as an impurity in 15N4-ARG.
3.4 Correlation between 15N3-CIT and 15N3-ARG vs. 15N-nitrite
To evaluate whether 15N3-CIT and 15N3-ARG production can estimate NOS activity, the peak intensities of 15N3-CIT and 15N3-ARG were compared to another index of NOS activity, 15N-nitirte production, by using cell samples after EA.hy926 human endothelial cells were exposed to different concentrations of 15N4-ARG for 2 hours. After incubation, an aliquot of the sample was used to determine peak intensities of 15N3-CIT and 15N3-ARG and an aliquot of the same sample was used to determine 15N-nitrite concentrations and two measurements were compared. The peak intensities of 15N3-CIT and 15N3-ARG increased with an increase in the observed 15N-nitrite concentration (Supplementary Fig. S2).
To test whether the combined 15N3-CIT + 15N3-ARG concentrations would correlate better to 15N-nitrite than 15N3-CIT alone, we estimated the concentrations 15N3-CIT and 15N3-ARG assuming the calibration curves. Based on this assumption, the contribution of 15N3-ARG, after correction as an impurity from added 15N4-ARG, was relatively small to the total estimated concentration of 15N3-CIT + 15N3-ARG. In principle, the metabolism of ARG to CIT and NO should produce a 1:1 ratio of these metabolites. However, results showed that the estimated concentrations of 15N3-CIT were 14.5-fold higher than those of 15N-nitrite (Supplementary Fig. S3). Statistical analyses of the data indicate significant correlations between 15N3-CIT vs. 15N-nitrite (Pearson correlation coefficient, p = 0.862, R2 = 0.740), 15N3-CIT + 15N3-ARG vs. 15N-nitrite (p = 0.865, R2 = 0.744), and 15N3-CIT vs. 15N3-ARG (p = 0.998, R2 = 0.931).
3.5 Comparison of kinetic parameters of NOS activity
Michaelis-Menten plots of estimated NOS activity based on the formation of different metabolic products as a function of 15N4-ARG concentration in the intact cells and cell lysates are shown in Fig. 3 and Fig. 4, respectively. In intact cells, the estimated Km values were independent of the metabolic product used. The Km in the intact cells were higher than that in the cell lysates. On the other hand, the estimates of Vmax varied depending on the metabolic product used. The estimated Vmax values were about 10-fold higher using either 15N3-CIT or 15N3-CIT+15N3-ARG, as compared to using 15N-nitrite as an indicator of metabolite formation in the intact cells (Table 2). Unlabeled nitrite and nitrate were also measured in the cell lysates. However, the 15N4-ARG concentration dependent production of unlabeled nitrite and nitrate was not clear, which hampered to estimate kinetic parameters likely due to the high baseline values (Supplementary Fig. S4).
Figure 3.
Michaelis-Menten plots of estimated NOS activity in EA.hy926 cells based on the formation of different metabolic products after exposure to 0 – 500 μM of 15N4-ARG for 2 hours (n=6 for each concentration). The drawn lines are fits to the observed data using the Michaelis-Menten equation.
Figure 4.
Michaelis-Menten plots of estimated NOS activity in EA.hy926 cell lysates based on the formation of 15N3-CIT after cell lysates were exposed to 0 – 100 μM of 15N4-ARG for 30 min (n=3 for each concentration). The drawn lines are fits to the observed data using the Michaelis-Menten equation.
Table 2.
Estimated parameters of NOS activity by using different metabolic products (n=6 for each 15N4-ARG concentration).
| Indicator | Vmax (pmol·mg−1·min−1) | Km (μM) |
|---|---|---|
| Estimate (CV%) | Estimate (CV%) | |
| Intact cells | ||
| 15N-Nitrite | 0.506 (11.9) | 46.6 (29.5) |
| 15N3-CIT | 4.22 (12.6) | 59.6 (28.1) |
| 15N3-CIT+15N3-ARG | 5.11 (13.1) | 68.0 (27.6) |
| Cell lysates | ||
| 15N3-CIT | 3.18 (9.3) | 5.33 (44.1) |
3.6 Effects of NOS inhibitor on 15N3-CIT production
Fig. 5 shows the effects of L-NAME on the production of 15N3-CIT in the cell lysates. In the presence of L-NAME at 100 μM in the reaction mixture, 15N3-CIT formation was significantly diminished (p <0.05).
Figure 5.
Production of 15N3-CIT in the human endothelial cell lysates after cell lysates were incubated with 15N4-ARG (100 μM) in the presence of NOS inhibitor, L-NAME (100 μM) for 30 min. Data are presented as the mean ± SD (n=3). *, p<0.05 vs. control (i.e., without 15N4-ARG). #, p<0.05 vs. 15N4-ARG (i.e., without L-NAME).
3.7 Application of 15N3-CIT assay to rat liver mitochondria
Arginase catalyzed conversion of 14C-ARG to 14C-urea has been suggested to present a confounding factor in using radioactive 14C-CIT as an index of NOS activity. This was pointed out by studies that showed apparent 14C-CIT conversion in rat liver mitochondria, which did not have NOS activity.[11, 21] Using the same rat liver mitochondria preparation, we examined whether 15N3-CIT formation can be observed.
Using cytochrome c oxidase activity as an index, we found that the isolated mitochondria fraction had a 5.5-fold enrichment in enzyme activity compared to whole homogenate, and a 17.0-fold enrichment compared to the supernatant fraction. Significant presence of 15N3-CIT was found to be formed when the whole liver homogenate was incubated with 15N4-ARG (Fig. 6). However, with the isolated rat mitochondria fraction, 2 of the 4 samples did not show any measurable 15N3-CIT, while the other two samples revealed marginal peak intensity. The mean 15N3-CIT peak intensity found in the mitochondria preparation was not statistically different with or without added 15N4-ARG. No appreciable 15N3-ARG was found in any of these samples.
Figure 6.
Production of 15N3-CIT in the whole rat liver homogenate or purified rat liver mitochondria fraction after incubation with 50 μM of 15N4-ARG for 10 min. Data are presented as the mean ± SD (n=4). ***, p<0.001 vs. control (i.e., without 15N4-ARG).
4 Discussion
In the present study, metabolite formation (15N3-CIT and 15N3-ARG) from stable isotope labeled ARG (15N4-ARG) was evaluated as a possible index of NOS activity in endothelial cells and cell lysates. When 15N4-ARG is used as a substrate for NOS, 15N3-CIT and 15NO should be produced at equal molar amounts (Fig. 2). After 15N3-CIT is produced, two urea cycle enzymes, i.e., argininosuccinate synthase and argininosuccinate lyase, convert it back to 15N3-ARG via 15N3-argininosuccinate, which couples with an unlabeled nitrogen from aspartate.[22, 23] Further metabolism of 15N3-ARG by NOS produces 15N3-CIT and unlabeled NO. Rapid equilibrium of the guanidine group possibly generate 15N2-CIT and 15NO from 15N3-ARG. However, 15N2-CIT was not detected (Table 1), indicating 15N3-CIT and unlabeled NO are dominantly produced from 15N3-ARG in our experimental system. Thus, after the first metabolic step of 15N4-ARG, subsequent urea cycle lead to repeated formation of 15N3-CIT and 15N3-ARG in a futile cycle (Fig. 2). Note that with the added substrate 15N4-ARG, only isotopically labeled 15N-NO (measured as 15N-nitrite) is produced. However, through the subsequent urea cycle (CIT→ARG recycling system), the NO comes from the unlabeled nitrogen atom derived from aspartate, and unlabeled NO was formed as a consequence.
While we could not determine the true concentrations of 15N3-CIT and 15N3-ARG in this study because authentic compounds are not yet available, we estimated their concentrations based on the assumption that the calibration curves of CIT and 15N4-ARG could be applied. A partial justification of this assumption is that the LC-MS/MS peak intensity responses of 14N-ARG, 15N4-ARG, 13C6-ARG were identical, and the calibration curves of 14N-ARG and 15N4-ARG gave the same slopes when 13C6-ARG was used as an internal standard.[12] Similarly, the LC-MS/MS peak intensity responses of 14N-CIT vs. D4-CIT were also identical. Thus, isotopic labeling of CIT and ARG did not appear to affect their chromatographic responses dramatically. Naturally, the validity of the assumption used must be confirmed experimentally using authentic compounds of 15N3-CIT and 15N3-ARG, if and when they become available.
Based on this estimation, 15N-nitrite production was positively related to either 15N3-CIT production alone, or to the combined 15N3-CIT + 15N3-ARG accumulation (Supplementary Fig. S3). However, 15N-nitrite levels were 14.5 ± 4.4 and 18.7 ± 5.6-folds less than those of 15N3-CIT alone, and combined 15N3 -CIT + 15N3-ARG, respectively. Higher levels of 15N-CIT compared to 15N-nitrite and 15N-nitrate were also reported when L-[guanidino-15N2]-ARG was used as a substrate.[24] The use of 15N-nitrite as a surrogate measure of produced 15NO also assumes that the predominant route of 15NO disappearance occurs through conversion to nitrite. However, it is possible that 15NO may be lost via evaporation and/or oxidized to other product, i.e. 15N-nitrate. Direct nitration of cellular proteins, e.g., to form nitrated tyrosine, is also possible. Thus, 15N-nitrite accumulation may represent an under-estimate of 15NO production. It is also possible that potential abundant interference and/or additional pathways are contributory to labeled CIT in cell systems.[24]
Analysis of NOS activity using isotopic-labeled ARG typically has been obtained via determination of 14C-CIT, formed from 14C-ARG. Flam et al.[25] reported that NO production which was measured by nitrite concentration, exceeded apparent 14C-CIT formation at least by 8-fold in bovine aortic endothelial cells, indicating that radioactive CIT formation may significantly underestimate the actual NO production. The favored formation of unlabeled nitrite over 14C-CIT is opposite to our present finding that 15N-nitrite levels were 14.5-folds lower than that of 15N3-CIT (Supplementary Fig. S3). This discrepancy, however, can be explained by tracking the fate of 14C-CIT and NO in the radioactive assay (Supplementary Fig. S5). Here, since the isotope labeling is made on the carbon atom, rather than the nitrogen atom, metabolism of 14C-ARG would generate unlabeled NO and urea cycle would form a futile cycle of 14C-CIT and 14C-ARG along with new formation of NO. Thus, utilization of 14C-CIT as an index of NOS production only measures NO production from the added substrate, and not from urea cycle. In contrast, use of unlabeled nitrite measures NO production from both the added substrate alone and from urea cycle.
Our results also indicate that the apparent production of 15N3-ARG, after correction for its presence as a chemical contaminant of 15N4-ARG, was only a marginal contributor for the estimation of NOS activity (Supplementary Fig. S3). Unlike 15N3-CIT, which has only one major metabolic pathway operating through urea cycle, 15N3-ARG can be metabolized by several other enzymes besides NOS, viz., arginine decarboxylase, arginine:glycine amidinotransferase and arginase.[26] Thus, 15N3-ARG may be partially removed from the futile 15N3-CIT→15N3-ARG cycle through these enzymes.
Kinetic analysis using the various metabolic products of 15N4-ARG showed that the Km values estimated from 15N3-CIT or 15N3-CIT +15N3-ARG were similar to those from 15N-nitrite, suggesting that all these metabolites utilize the same enzyme. The magnitude of Km we observed in the intact endothelial cells is consistent with a value of 29 ± 6 μM in bovine aortic endothelial cells, using radiolabeled ARG to CIT conversion as an index.[27] The Km estimates in the cell lysates in the present study were also comparable with the literature reports of ~ 3 μM which was determined in the isolated enzyme preparation.[27] The higher Km in the intact cells compared with that in the cell lysates may be contributed to the 15N4-ARG transport into the cell before its metabolism. As discussed, the different Vmax estimated values obtained likely reflected the underestimation of 15NO production when 15N-nitrite was used as the metabolite index.
Finally, we tested the application of this LC-MS/MS method to estimate NOS activity in the rat liver mitochondria preparation.[11, 21] The presence of mitochondrial NOS has long been disputed. Several investigators have pointed out errors in methodologies used in documenting this activity[28–30] including the presence of apparent activity which could not be blocked by NOS inhibitors. Recently, it was shown that the apparent 14C-CIT radioactivity signal may have included 14C-urea, which is formed via arginase-mediated metabolism of ARG.[11, 21] Here, we showed that insignificant 15N3-CIT formation in rat liver mitochondria, while significant accumulation of this metabolite can be observed in rat liver homogenates.
The use of 15N3-CIT as an index of NOS activity in cell culture studies may possess several technical advantages over that of 14C-CIT. First, stable isotopes are used in place of radioactive compounds, enabling better safety and easier disposal of experimental waste. Second, the LC-MS/MS method offers additional assay capabilities as other ARG-related compounds such as the dimethylarginines can also be simultaneously determined. Third, the identity of the studied compounds can be made with better certainty because the LC-MS/MS method incorporates chromatographic separation and mass identification along with fragmentation patterns.
Compared to the use of inorganic nitrite as an index of generated NO activity, the present method may also possesses several advantages. First, endogenous (unlabeled) nitrite levels in biological systems are high (in μM’s), so the detection of generated NO (as measured by nitrite) lacks sensitivity. Second, as mentioned previously, the conversion of NO to nitrite in biological systems may not be complete because of NO evaporation and other reactions. The present method suggests that the sum of 15N3-CIT and 15N3-ARG would represent the total NO produced from the added 15N4-ARG substrate.
However, the current method also carries some disadvantages. First, an authentic standard of 15N3-CIT is not yet available to allow for unambiguous estimation of the concentrations of the compound. Second, LC-MS/MS methods are more costly to run, and require more extensive instrumentation and resources. However, the present study points out the potential utility of LC-MS/MS methodology as an alternative for the existing 14C-CIT assay in determining NOS activity.
5 Conclusions
When 15N4-ARG is used as a substrate in cell culture studies, metabolite formation of 15N3-CIT may be used as a surrogate indicator of NO generation and assessment of NOS activity. Determination of this isotopic metabolite may allow for the simple and sensitive examination of NO production from the exogenous ARG.
Supplementary Material
Acknowledgments
This work was supported by the National Research Foundation of Korea (NRF) grant NRF-2012R1A1A1044923 and NIH grant HL81580.
Footnotes
Conflict of interest
The authors have declared no conflict of interest.
References
- 1.Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109. [PubMed] [Google Scholar]
- 2.Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121. doi: 10.1161/01.hyp.23.6.1121. [DOI] [PubMed] [Google Scholar]
- 3.Tsikas D. A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research. Anal Biochem. 2008;379:139. doi: 10.1016/j.ab.2008.04.018. [DOI] [PubMed] [Google Scholar]
- 4.Czapski G, Goldstein S. The role of the reactions of .NO with superoxide and oxygen in biological systems: a kinetic approach. Free Radic Biol Med. 1995;19:785. doi: 10.1016/0891-5849(95)00081-8. [DOI] [PubMed] [Google Scholar]
- 5.Griess P, Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt “Ueber einige Azoverbindungen”. Berichte der deutschen chemischen Gesellschaft. 1879;12:426. [Google Scholar]
- 6.Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 1993;214:11. doi: 10.1006/abio.1993.1449. [DOI] [PubMed] [Google Scholar]
- 7.Helmke SM, Duncan MW. Measurement of the NO metabolites, nitrite and nitrate, in human biological fluids by GC-MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851:83. doi: 10.1016/j.jchromb.2006.09.047. [DOI] [PubMed] [Google Scholar]
- 8.Rejdak K, Petzold A, Sharpe MA, Smith M, Keir G, Stelmasiak Z, Thompson EJ, Giovannoni G. Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injury. J Neurol Sci. 2003;208:1. doi: 10.1016/s0022-510x(02)00412-4. [DOI] [PubMed] [Google Scholar]
- 9.Avogaro A, Toffolo G, Kiwanuka E, de Kreutzenberg SV, Tessari P, Cobelli C. L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes. 2003;52:795. doi: 10.2337/diabetes.52.3.795. [DOI] [PubMed] [Google Scholar]
- 10.Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682. doi: 10.1073/pnas.87.2.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Venkatakrishnan P, Nakayasu ES, Almeida IC, Miller RT. Arginase activity in mitochondria--An interfering factor in nitric oxide synthase activity assays. Biochem Biophys Res Commun. 2009;394:448. doi: 10.1016/j.bbrc.2009.10.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Shin S, Fung SM, Mohan S, Fung HL. Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:467. doi: 10.1016/j.jchromb.2011.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Closs EI, Scheld JS, Sharafi M, Forstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol. 2000;57:68. [PubMed] [Google Scholar]
- 14.Simon A, Plies L, Habermeier A, Martine U, Reining M, Closs EI. Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. Circ Res. 2003;93:813. doi: 10.1161/01.RES.0000097761.19223.0D. [DOI] [PubMed] [Google Scholar]
- 15.Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80:3734. doi: 10.1073/pnas.80.12.3734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Mohan S, Wu CC, Shin S, Fung HL. Continuous exposure to L: -arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Amino Acids. 2011;43:1179. doi: 10.1007/s00726-011-1173-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265. [PubMed] [Google Scholar]
- 18.Raha S, McEachern GE, Myint AT, Robinson BH. Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase. Free Radic Biol Med. 2000;29:170. doi: 10.1016/s0891-5849(00)00338-5. [DOI] [PubMed] [Google Scholar]
- 19.Shin S, Fung HL. Evaluation of an LC-MS/MS assay for (15)N-nitrite for cellular studies of l-arginine action. J Pharm Biomed Anal. 2011;56:1127. doi: 10.1016/j.jpba.2011.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang H, Zhang D, Ray K, Zhu M. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J Mass Spectrom. 2009;44:999. doi: 10.1002/jms.1610. [DOI] [PubMed] [Google Scholar]
- 21.Venkatakrishnan P, Nakayasu ES, Almeida IC, Miller RT. Absence of nitric-oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem. 2009;284:19843. doi: 10.1074/jbc.M109.003301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A. 1990;87:8612. doi: 10.1073/pnas.87.21.8612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wu G, Morris SM., Jr Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1. doi: 10.1042/bj3360001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bohmer A, Gambaryan S, Flentje M, Jordan J, Tsikas D. [Ureido-15N]citrulline UPLC-MS/MS nitric oxide synthase (NOS) activity assay: development, validation, and applications to assess NOS uncoupling and human platelets NOS activity. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;965:173. doi: 10.1016/j.jchromb.2014.06.025. [DOI] [PubMed] [Google Scholar]
- 25.Flam BR, Eichler DC, Solomonson LP. Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide. 2007;17:115. doi: 10.1016/j.niox.2007.07.001. [DOI] [PubMed] [Google Scholar]
- 26.Morris SM., Jr Arginine: beyond protein. Am J Clin Nutr. 2006;83:508S. doi: 10.1093/ajcn/83.2.508S. [DOI] [PubMed] [Google Scholar]
- 27.Hardy TA, May JM. Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells. Free Radic Biol Med. 2002;32:122. doi: 10.1016/s0891-5849(01)00781-x. [DOI] [PubMed] [Google Scholar]
- 28.Brookes PS. Mitochondrial nitric oxide synthase. Mitochondrion. 2004;3:187. doi: 10.1016/j.mito.2003.10.001. [DOI] [PubMed] [Google Scholar]
- 29.Lacza Z, Snipes JA, Zhang J, Horvath EM, Figueroa JP, Szabo C, Busija DW. Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS. Free Radic Biol Med. 2003;35:1217. doi: 10.1016/s0891-5849(03)00510-0. [DOI] [PubMed] [Google Scholar]
- 30.Giraldez RR, Zweier JL. An improved assay for measurement of nitric oxide synthase activity in biological tissues. Anal Biochem. 1998;261:29. doi: 10.1006/abio.1998.2721. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






